Stocks
Actinium Pharmaceuticals, Inc.ATNM
AMEXHealthcareBiotechnology$1.52
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing targeted radiotherapy for cancer treatment. Its lead program, Actinium-225-based therapies, targets advanced cancers, and the company holds a pipeline of products in various stages of clinical development. Investors track ATNM for its potential in the emerging field of alpha-emitting radiopharmaceuticals.
52W Range: $0.73-$1.74
Congressional Interest in Actinium Pharmaceuticals, Inc. (ATNM)
No congressional trades have been disclosed for Actinium Pharmaceuticals, Inc. (ATNM) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading ATNM?
No congressional trades found for this stock.